Previous Article
Antimicrobial Agents and Chemotherapy, September 2008, p. 3465-3466, Vol. 52, No. 9
0066-4804/08/$08.00+0 doi:10.1128/AAC.00445-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Novel Mutation in 23S rRNA That Confers Low-Level Resistance to Clarithromycin in Helicobacter pylori

LETTER
In many countries, the occurrence of clarithromycin-resistant
Helicobacter pylori has become increasingly common. The MICs
of clarithromycin in most clinical
H. pylori strains are either

2 mg/liter or

0.125 mg/liter (
3). Recently, we isolated two
stable
H. pylori isolates with low-level clarithromycin resistance
from different patients (TS1900 and TS1776), and these isolates
showed MICs of 1 mg/liter and 0.5 mg/liter, respectively. It
has been previously shown that clarithromycin-resistant strains
with MICs exceeding 2 mg/liter were characterized by mutations
in the 23S rRNA gene at positions 2058 and 2059 (by
Escherichia coli numbering, corresponding to positions 2142 and 2143 in
H. pylori), which resulted in a decreased affinity of clarithromycin
for ribosomes (
9,
11). However, we failed to detect mutations
at those positions of the 23S rRNA gene in the weakly clarithromycin-resistant
isolates TS1900 and TS1776. Fontana et al. recently reported
that a mutation at position 2628 in
E. coli numbering (corresponding
to position 2717 in
H. pylori) also conferred low-level clarithromycin
resistance (
1); however, both TS1900 and TS1776 had wild-type
nucleic acids at that position.
Upon comparing the sequence of the 23S rRNA gene of ATCC 700392 (a clarithromycin-susceptible strain) to the sequence of the same gene in TS1900, we identified 13 substitutions corresponding to positions 720, 759, 1513, 1563, 1564, 1644, 1687, 1821, 1826, 1830, 2182 (2098), 2190 (2106), and 2694 (2611) of the H. pylori 23S rRNA gene (E. coli numbering in parentheses). In order to determine the contribution of these 23S rRNA gene mutations to low-level clarithromycin resistance, ATCC 700392 was transformed with regions of the 23S rRNA gene of TS1900 by using a transformation method described previously (5). We obtained transformants with low-level clarithromycin resistance when ATCC 700392 was transformed with the PCR products of regions of the TS1900 23S rRNA gene consisting of positions 626 to 2774, 1931 to 2774, 2276 to 2774, and 2569 to 2774 (Table 1). Intriguingly, all transformants with low-level clarithromycin resistance that were obtained in this study possessed the mutation C2611A in E. coli numbering (corresponding to position C2694 of H. pylori) in the 23S rRNA gene. Notably, because the size of the colony was not influenced by the transformation and MICs for the transformants were also stable in serial subcultures, the presence of the mutation C2611A had no effect on the overall growth of the transformants. Moreover, while the mutation T2098C (corresponding to T2182C of H. pylori) has been reported to confer clarithromycin resistance (2), the results of this study suggested that this mutation was not required for clarithromycin resistance to be conferred, at least in a background also containing the C2611A mutation.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Gene mutations in 23S rRNA and clarithromycin susceptibility in transformants with low-level clarithromycin resistance
|
In addition to TS1900, the weakly clarithromycin-resistant isolate
TS1776 also possessed the C2611A mutation in its 23S rRNA gene.
DNA sequencing analysis of the 23S rRNA gene from 58 clinical
isolates in Japan from 1996 to 2006 indicated that the C2611A
mutation was not detected in any clarithromycin-susceptible
(
n = 21) or clarithromycin-resistant (
n = 37) isolate. Furthermore,
the C2611A mutation was not detected in any 23S rRNA gene of
H. pylori reported in the DNA Data Bank of Japan. These data
suggest that the C2611A mutation can be associated with low-level
clarithromycin resistance in
H. pylori.
It was previously reported that mutations of base pairs 2057 to 2611 in 23S rRNA affect the efficacy of erythromycin by reducing the affinity of erythromycin for the ribosome in many bacterial species (4, 6, 8, 10). Since clarithromycin targets the same region of 23S rRNA as erythromycin (7), these data strongly suggest that the C2611A mutation in 23S rRNA of our isolated H. pylori strains may introduce a steric hindrance that prevents efficient clarithromycin binding, thus conferring the low-level resistance to clarithromycin observed in our study.

ACKNOWLEDGMENTS
We thank Y. Kojima and M. Nagata for their technical assistance.
This work was supported by both the High-Tech Research Centre Project for Private Universities funded by the Ministry of Education, Culture, Sports, Science, and Technology.

FOOTNOTES

Published ahead of print on 7 July 2008.


REFERENCES
1 - Fontana, C., M. Favaro, S. Minelli, A. A. Criscuolo, A. Pietroiusti, A. Galante, and C. Favalli. 2002. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob. Agents Chemother. 46:3765-3769.[Abstract/Free Full Text]
2 - Khan, R., S. Nahar, J. Sultana, M. M. Ahmad, and M. Rahman. 2004. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob. Agents Chemother. 48:3567-3569.[Abstract/Free Full Text]
3 - Kim, J. M., J. S. Kim, H. C. Jung, N. Kim, Y. J. Kim, and I. S. Song. 2004. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. Antimicrob. Agents Chemother. 48:4843-4847.[Abstract/Free Full Text]
4 - Pfister, P., N. Corti, S. Hobbie, C. Bruell, R. Zarivach, A. Yonath, and E. C. Bottger. 2005. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A
G. Proc. Natl. Acad. Sci. USA 102:5180-5185.[Abstract/Free Full Text] 5 - Rimbara, E., N. Noguchi, T. Kawai, and M. Sasatsu. 2008. Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J. Antimicrob. Chemother. 61:995-998.[Abstract/Free Full Text]
6 - Ross, J. I., A. M. Snelling, E. A. Eady, J. H. Cove, W. J. Cunliffe, J. J. Leyden, P. Collignon, B. Dreno, A. Reynaud, J. Fluhr, and S. Oshima. 2001. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the USA, Japan and Australia. Br. J. Dermatol. 144:339-346.[CrossRef][Medline]
7 - Schlünzen, F., R. Zarivach, J. Harms, A. Bashan, A. Tocilj, R. Albrecht, A. Yonath, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413:814-821.[CrossRef][Medline]
8 - Tait-Kamradt, A., T. Davies, M. Cronan, M. R. Jacobs, P. C. Appelbaum, and J. Sutcliffe. 2000. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44:2118-2125.[Abstract/Free Full Text]
9 - Taylor, D. E., Z. Ge, D. Purych, T. Lo, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 41:2621-2628.[Abstract]
10 - Vannuffel, P., M. Di Giambattista, E. A. Morgan, and C. Cocito. 1992. Identification of a single base change in ribosomal RNA leading to erythromycin resistance. J. Biol. Chem. 267:8377-8382.[Abstract/Free Full Text]
11 - Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480.[Abstract]
| | | | | |
Emiko Rimbara
Norihisa Noguchi*
Department of Microbiology School of Pharmacy Tokyo University of Pharmacy and Life Sciences 1432-1 Horinouchi, Hachioji-shi, Tokyo 192-0392, Japan
Takashi Kawai
Endoscopy Center Tokyo Medical University 6-7-1 Nishi-Shinjuku Shinjuku-ku, Tokyo 160-0023, Japan
Masanori Sasatsu
Department of Microbiology School of Pharmacy Tokyo University of Pharmacy and Life Sciences 1432-1 Horinouchi, Hachioji-shi, Tokyo 192-0392, Japan
|
| | | | | |
* Phone: 81-426-76-5615 Fax: 81-426-76-5647 E-mail: noguchin{at}ps.toyaku.ac.jp |
Antimicrobial Agents and Chemotherapy, September 2008, p. 3465-3466, Vol. 52, No. 9
0066-4804/08/$08.00+0 doi:10.1128/AAC.00445-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cambau, E., Allerheiligen, V., Coulon, C., Corbel, C., Lascols, C., Deforges, L., Soussy, C.-J., Delchier, J.-C., Megraud, F.
(2009). Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori. J. Clin. Microbiol.
47: 3600-3607
[Abstract]
[Full Text]